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IMPROVING PROVIDER KNOWLEDGE IN THE EVALUATION, DIAGNOSIS, 
AND TREATMENT OF ADHD 
 
 
An Abstract of the Project by 
Amanda Swink, MSN, FNP-C 
 
 
Pediatric diagnosis of attention deficit hyperactivity disorder (ADHD) is on the 
rise with an increasing financial burden to the healthcare system and the patient (Center 
for Disease Control, 2015).  This study sought to determine if an educational intervention 
would increase the knowledge of primary care providers in respect to ADHD clinical 
practice guidelines and the diagnosis and treatment of pediatric patients.  An initial online 
survey was administered to primary care nurse practitioners in an attempt to determine 
their knowledge level, provider feelings and current practices in regards to pediatric 
ADHD in this region.  Approximately four weeks after the online survey, an educational 
intervention based on the American Academy of Pediatrics (AAP) Clinical Practice 
Guideline (CPG) for ADHD was provided to primary care nurse practitioners.   
A pretest was given to participants followed by a PowerPoint presentation and then a 
posttest. A t-test was conducted on the pretest and posttest results. The study concluded 
with substantial statistical significance (p < 0.001) that the educational intervention 
increased knowledge of the AAP CPG for ADHD. All participants (n=21) had an 
increase in posttest scores after the educational intervention. This study supports a need 
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Attention Deficit Hyperactivity Disorder (ADHD) is a significant health care 
issue in the United States that effects millions (CDC, 2015). According to the Fifth 
Edition of the Diagnostic and Statistical Manual of Mental Disorders/DSM-5(2013), 
ADHD is "a persistent pattern of inattention and/or hyperactivity-impulsivity that is more 
frequently displayed and more severe than is typically observed in individuals at a 
comparable level of development" (p. 59-65). According to the Centers for Disease 
Control (2015), “The percentage of children with an ADHD diagnosis continues to 
increase, from 7.8% in 2003 to 9.5% in 2007 and to 11.0% in 2011” (In the United States 
section, para. 4).  
The U.S. National Library of Medicine (2014) defines ADHD as, “a problem of 
not being able to focus, being overactive, not being able to control behavior, or a 
combination of these. For these problems to be diagnosed as ADHD, they must be out of 
the normal range for a person's age and development” (para. 1.). Secondary sources were 
also reviewed.  The references reported very similar definitions of ADHD.  There were 





The rates of ADHD have been steadily increasing and the financial burden is 
significant. “The total excess cost of ADHD in the US in 2000 was $31.6 billion. Of this 
total, $1.6 billion was for the treatment of patients, $12.1 billion was for all other health 
care costs of persons with ADHD, $14.2 billion was for all other health care costs of 
family members with ADHD, and $3.7 billion was for the work loss cost of adults with 
ADHD and adult family members of persons with ADHD” (CDC, 2015 Economic Cost 
section, bullet 3). The effects of this diagnosis are widespread, including psychosocial, 
educational, financial, and within the workforce. For this reason, it is vital that patients 
have access to effective diagnosis and treatment.  
ADHD is a chronic disorder, the effects of which begin in childhood. 
Management of a condition with emotional, physical, intellectual and environmental 
components is taxing and requires understanding of many areas of specialization, 
particularly when addressing pediatric patients. The Clinical Practice Guideline that is 
currently recommended for use was created specifically for primary care providers to 
meet the ever-growing need for ADHD management (AAP, 2011).  Education on the 
American Academy of Pediatrics (AAP) Clinical Practice Guideline (CPG) can help 
providers with diagnosis and treatment of ADHD.  
Statement of Problem 
 Treatment and management of ADHD in the primary care setting can be a 
difficult and lengthy task.  Because treatment requires information from the patient, 
caregivers, and teachers, this is time-consuming and involves communication with many 




definitive test to confirm ADHD. Providers report that they are uncomfortable treating a 
condition that involves pediatric patients and a psychiatric diagnosis (Wright, 2014). 
The AAP acknowledges that some primary care clinicians might not be confident 
of their ability to successfully diagnose and treat ADHD in a child because of the 
child’s age, coexisting conditions, or other concerns. At any point at which a 
clinician feels that he or she is not adequately trained or is uncertain about making 
a diagnosis or continuing with treatment, a referral to a pediatric or mental health 
subspecialist should be made (AAP, 2011, p.5).   
Wright noted, “many primary care providers are uncomfortable with the treatment of 
mental health issues, particularly ADD (Attention Deficit Disorder)/ADHD” (Wright, 
2014 slide 3). 
A number of specialists are qualified to conduct ADHD diagnostic evaluations 
such as psychologists, psychiatrists, educational specialists, neurologists and 
pediatricians. Owing to the high prevalence of ADHD, the limited number of specialists 
(e.g., developmental-behavioral pediatricians, child psychiatrists) and common insurance 
reimbursement restrictions on ADHD diagnostic evaluations, many children present to 
and are evaluated by primary care providers (Langberg, Froehlich, Loren, Martin, & 
Epstein, 2008). Physician demand is expected to increase seventeen percent, demand will 
then exceed supply by a range of 46,000 to 90,000 by the year 2025; which correlates to a 
shortage of between 12,500 and 31,100 primary care physicians (AAMC, 2015).  This 
shortage of primary care physicians may affect access and treatment including referrals to 




and address the health care shortage. Primary care providers are called to treat the whole 
patient and patients of all ages which includes pediatric patients with ADHD.   
Primary care providers (PCPs) include primary care physicians, nurse 
practitioners, and physician assistants.  PCPs must now act beyond the role of 
gatekeepers for mental health and treat psychiatric conditions.  “Children with ADHD are 
frequently encountered in the primary care setting. It is important that the diagnosis of 
this condition by primary care providers be based on procedures supported by evidence 
from empirical investigations” (AAP, 2001, p. 9).  The need for mental health care 
services including the treatment of ADHD is even more prevalent in rural health care 
shortage areas where access to a specialist is limited both in number and by factors such 
as travel time and cost to the patient (HRSA, 2015; Palmer, Myers, Stoep, McCarty, 
Geyer, & DeSalvo, 2010).  Primary care providers need to be well versed and 
comfortable in evaluating, diagnosing and treating ADHD as it effects 11% of pediatric 
patients in the United States (CDC, 2015).  Current clinical practice guidelines show that 
ADHD can be treated at the primary care level (AAP, 2011).   
Dr. Amanda Itzkoff, Assistant Professor, Department of Psychiatry at Mount 
Sinai Hospital in New York City reports, “What many primary care physicians truly need 
is good mental health training, an established link to a skilled child psychiatrist for 
slightly complicated cases, and the knowledge of when to appropriately refer patients” 
(Forbes, 2015, para. 15). The component that can be most readily addressed is good 
mental health training.  Palmer et al. (2010), report, one of the most prevalent psychiatric 
disorders diagnosed in children and adolescents is ADHD.  This disorder is equally 




management of ADHD is limited for patients of ethnic and racial minorities and those 
living in rural areas. 
Significance to Nursing 
The rates of ADHD are continuing to rise (CDC, 2015).  Primary care physicians 
and nurse practitioners have the opportunity to help meet the need of patients in areas 
with limited access to psychiatric and pediatric providers.  Early diagnosis of ADHD and 
effective treatments (behavior and/or pharmacological) show improved classroom 
performance, improved self-esteem of patients, and decreased family stress (AAP, 2011; 
Palmer et al, 2010).  Providers need to consider evaluating for this chronic condition 
during wellness exams and as indicated by caregiver or teacher concerns.  Primary care 
providers must become informed about ADHD in order to recognize what does and does 
not constitute diagnosis, when behavioral therapy alone is acceptable, and when 
pharmacological treatment is indicated to achieve quality outcomes.  According to Leslie 
(2002), “It is critical for primary care clinicians to develop competency in the early 
recognition, identification, and treatment of this condition” (Pediatric Annals, 2002 para. 
3).  
Access to interventions for ADHD is an important public health concern. ADHD 
affects many areas that may prevent a person from achieving their maximum potential.  
Access to diagnosis and treatment is needed to improve patient outcomes (CDC, 2015). 
Leslie (2002) reported, clinicians stress the challenges of ADHD management and the 
use of CPGs in their practices along with reporting unique barriers to ADHD 
management.  These multiple barriers that prevent patients from receiving services for 




behavior disorders, lack of access to providers accepting psychiatric patients, and under-
identification or misidentification of the disorder. Current practices in the diagnosis and 
treatment of ADHD are not uniform.  The CDC (2015) also reports, “Nationally, we must 
begin to look at a wide variety of intervention issues surrounding ADHD, including how 
current interventions impact individuals and systems over time, as well as problems with 
access to appropriate services” (Interventions for ADHD section, para. 4). They go on to 
recommend action to address public health needs.  One of the actions recommended is, 
“Disseminate educational materials relating to the diagnosis of and intervention 
opportunities for ADHD” (CDC, 2015, Interventions for ADHD section, para.4).  
According to the CDC (2015) those receiving education should include primary care 
physicians, physician extenders (NP's and PA's), mental health professionals, and 
educators.  
Purpose  
This project plans to educate nurse practitioners on the evaluation, diagnosis, and 
treatment of ADHD through increased knowledge of the clinical practice guidelines.  The 
goal of the education is to increase providers’ knowledge base to better treat the growing 
population of pediatric ADHD patients.  The purpose of this evidence-based research 
project is to 1) provide data related to rural primary care providers’ knowledge of treating 
pediatric patients with ADHD; 2) increase awareness of the current Clinical Practice 
Guidelines (CPG) and algorithms; and 3) improve knowledge of pediatric ADHD 
management in primary care providers.  It is important to understand what is currently 
taking place at the clinical level to develop effective mechanisms to improve quality and 




The ever-increasing incidence of ADHD, financial burden of this condition, and the 
shortage of psychiatric and pediatric health care providers indicate the need for education 
of primary care providers on the current clinical practice guidelines (CDC, 2015).  
Education that focuses on increasing providers’ knowledge and comfort level are needed 
to help address this chronic disorder. 
Conceptual Framework 
The conceptual framework chosen for this project was Nola Pender’s Health 
Promotion Model.  This model addresses health promotion and well-being as a whole as 
opposed to simply the absence of illness.  Pender’s theory notes, each person has unique 
personal characteristics which effect the person’s actions. The set of variables for 
behavior specific knowledge and its affects are important to determine motivational 
methods. The variables can be changed through nursing actions. The desired outcome of 
the model is health promoting behavior (Health Promotion Model, 2016, para. 3). 
The Health Promotion Model makes four assumptions: 
1. Individuals seek to actively regulate their own behavior. 
2. Individuals, in all their biopsychosocial complexity, interact with the 
environment, progressively transforming the environment as well as being 
transformed over time. 
3. Health professionals, such as nurses, constitute a part of the interpersonal 
environment, which exerts influence on people through their life span. 
4. Self-initiated reconfiguration of the person-environment interactive patterns is 




There are thirteen theoretical statements that come from the model. They provide a 
basis for investigative work on health behaviors. The statements are: 
1. Prior behavior and inherited and acquired characteristics influence beliefs, 
affect, and enactment of health-promoting behavior. 
2. Persons commit to engaging in behaviors from which they anticipate deriving 
personally valued benefits. 
3. Perceived barriers can constrain commitment to action, a mediator of behavior 
as well as actual behavior. 
4. Perceived competence or self-efficacy to execute a given behavior increases the 
likelihood of commitment to action and actual performance of the behavior. 
5. Greater perceived self-efficacy results in fewer perceived barriers to a specific 
health behavior. 
6. Positive affect toward a behavior results in greater perceived self-efficacy, 
which can in turn, result in increased positive affect. 
7. When positive emotions or affect are associated with a behavior, the 
probability of commitment and action is increased. 
8. Persons are more likely to commit to and engage in health-promoting behaviors 
when significant others model the behavior, expect the behavior to occur, and 
provide assistance and support to enable the behavior. 
9. Families, peers, and health care providers are important sources of 
interpersonal influence that can increase or decrease commitment to and 




10. Situational influences in the external environment can increase or decrease 
commitment to or participation in health-promoting behavior. 
11. The greater the commitments to a specific plan of action, the more likely 
health-promoting behaviors are to be maintained over time. 
12. Commitment to a plan of action is less likely to result in the desired behavior 
when competing demands over which persons have little control require 
immediate attention. 
13. Persons can modify cognitions, affect, and the interpersonal and physical 
environment to create incentives for health actions (Pender, 2011, pp. 5-6).  This 
model acknowledges the many factors that can affect outcomes of this project.   
The overall focus will be on number eight, by modeling the expectations for 
ADHD evaluation and treatment while providing assistance through education to enable 
the behavior.  The implementation of this project is to provide assistance through 
education to increase knowledge of providers in the treatment of ADHD through the use 
of CPGs.  Information on ADHD will hopefully improve the self-efficacy of healthcare 
providers in the treatment of ADHD. The CPG from the AAP will serve as the plan of 
action to provide assistance to providers. Through the provided education these 
components will be combined to positively affect providers’ knowledge with the 
management of ADHD. 
Pender’s Health Promotion Model provides the theoretical bases for this evidence-
based project and serves as a guide for nurses and practitioners in clinical practice who 





Research Questions  
The research questions for this study are: 
1. Will an educational intervention increase the knowledge of primary care 
providers when identifying diagnostic criteria that is based on current practice 
guidelines for pediatric ADHD? 
2. Will an educational intervention increase the knowledge of primary care 
providers when selecting appropriate treatment for children based on current 
practice guidelines for pediatric ADHD? 
3. Will an educational intervention increase the primary care providers’ knowledge 
of the AAP algorithm and its components? 
Definition of Key Terms 
The following definitions are provided for the purpose of this study. 
 Attention Deficit Hyperactivity Disorder-- a problem of not being able to focus, 
being overactive, not being able to control behavior, or a combination of these. 
For these problems to be diagnosed as ADHD, they must be out of the normal 
range for a person's age and development (Medline Plus, 2014).  
 Clinical Practice Guideline-- Statements that include recommendations intended 
to optimize patient care that are informed by a systematic review of evidence and 
an assessment of the benefits and harms of alternative care options (National 
Guideline Clearinghouse, 2011).  
 Education-- the knowledge and development resulting from an educational 




 Nurse Practitioner-- licensed, independent practitioners who practice in 
ambulatory, acute and long-term care as primary and/or specialty care providers. 
Nurse practitioners assess, diagnose, treat, and manage acute episodic and chronic 
illnesses. NPs are experts in health promotion and disease prevention. They order, 
conduct, supervise, and interpret diagnostic and laboratory tests, prescribe 
pharmacological agents and non-pharmacologic therapies, as well as teach and 
counsel patients, among other services (AANP, 2015). 
 Pediatric(s)-- the specialty of medical science concerned with the physical, 
mental, and social health of children from birth to young adulthood. Pediatric care 
encompasses a broad spectrum of health services ranging from preventive health 
care to the diagnosis and treatment of acute and chronic diseases (AAP, 2015). 
 Primary Care Provider-- A primary care provider (PCP) is a health care 
practitioner who sees people that have common medical problems. This person is 
usually a doctor, but may be a physician assistant or a nurse practitioner (Medline 
Plus, 2014). 
 Provider—A term used by managed care organizations, referring to anyone 
rendering medical care, including physicians, nurse practitioners, physician 
assistants, and others (Farlex Partner Medical Dictionary, 2012). 
 Rural-- encompasses all population, housing, and territory not included within an 








In this study, the researcher assumed that the pre- and post-test questions were 
answered honestly (both academically and personally).  These questions were to be an 
accurate assessment of current recommendations for practice with the nurse practitioner 
providers having a basic knowledge of ADHD and able to understand the material 
without difficulty. In addition, both tests will accurately reflect the population studied.  
Summary 
ADHD is a chronic health disorder noted to have a significant impact on the 
United States.  Rates of ADHD continue to increase across the nation; at the same time, 
there is a shortage of psychiatric and pediatric health care providers (AAMC, 2015; CDC, 
2015). Primary care providers have the opportunity to fill this gap and meet the needs of 
this pediatric population. Guidelines were implemented by the AAP in 2011 that 
acknowledge the ability of a PCP to evaluate, diagnosis, and treat ADHD.  Yet, there is 
still a noted lack of knowledge and comfort level possessed by many PCPs which inhibits 
clinical management (Leslie, 2002). 
 Due to the fact that, “ADHD is the most common neurobehavioral disorder of 
childhood and can profoundly affect the academic achievement, well-being, and social 
interactions of children” (AAP, 2011, abstract) it is imperative that providers provide 
effective care and follow current guidelines. Most general practitioners and nurses will 
have undergone no or very little training in child and adolescent psychiatry. Ball (2002) 
reported, many general practitioners do not feel confident about their skills in recognizing 
and undertaking follow-up management of ADHD and feel that education is essential.  




practice guidelines and tools (algorithms, hand-outs and websites) to assist providers in 





















Review of Literature 
 
 
This review summarizes important findings, interventions, and limitations 
previously studied in the articles selected for this project. The literature indicates why 
ADHD is an important healthcare issue in the United States.  The review examined 
important data in regards to patient’s access to care for mental health throughout the 
nation, but most notably in rural areas with consideration given to variables that are 
barriers to improving access to ADHD diagnosis and management including: provider 
shortage and lack of provider education.  Finally, a review of current practice guidelines 
was completed to fully understand what provider education is readily available. 
A literature search was conducted using relevant databases, including CINAHL, 
ProMed, and several others provided by Pittsburg State University’s library 
services.  Initial searches used to retrieve articles included ADHD, providers’ knowledge 
of ADHD, providers’ comfort treating ADHD, knowledge of current clinical practice 
guidelines on ADHD, primary care providers treating ADHD, health care shortages, and 
tools to assist in ADHD treatment. Secondary sources were utilized including the 
American Academy of Pediatrics and American Psychiatric Association’s DSM-V in 
addition to the National Institutes of Health.  Information and current statistics were 




Network of Libraries of Medicine, and MedlinePlus.  There have been many articles 
published in the last twenty years about ADHD.  These articles attempt to determine a 
causation, effective diagnosis, and effective treatment of ADHD in the United States.  
After review of initial search results the following keywords were noted:  
 Attention Deficit Hyperactivity Disorder 
  Primary Care 




The identified key words, were used to search for articles. Thirty-two articles were 
identified as possible articles for analysis.  From the obtained articles, the following 
criteria were used: 
 Published in the last ten years 
 Children age 4-18 
 Interventions: Provider focused 
Fifty-two studies/meta-analyses met the inclusion criteria for analysis.  
Financial Impact of ADHD 
 ADHD has a financial impact on patients and their family members.  According 
to the CDC (2015), the total excess cost of ADHD in the US in 2000 was $31.6 billion. 
This cost was calculated by determining costs of healthcare and work loss for those with 
ADHD and their family members.  Of these monies, $14.2 billion healthcare costs of 




adults with ADHD and adult family members of persons with ADHD.  As these numbers 
illustrate the annual cost of ADHD in the US is significant. Patients with treated and 
untreated ADHD can create an economic burden on the healthcare system.   Comparisons 
of medical costs for those with and without ADHD consistently show higher annual costs 
for patients with ADHD. A study completed by Swensen et al. (2003), suggests that 
childhood ADHD places an economic burden on the child’s family members. The study 
analysis utilized data from 1996–1998 with a sample of 100,000 beneficiaries showing 
that family members of children with ADHD had 1.6 times as many medical claims as 
the control group.  The larger number of claims resulted in higher costs overall for these 
individuals.  According to the authors, annual direct medical costs were double for family 
members of ADHD patients ($2,740) compared to control patients ($1,365). Indirect 
costs related to disability and absenteeism was also noted.  These losses also showed 
increased financial costs for family members of ADHD patients (family members of 
ADHD patients, $888; family members of controls, $551).  
 In a survey of over 7000 individuals across ten different countries, De Graaf et al. 
(2008) found that adult ADHD is associated with substantial loss in role performance and 
an estimated 143.8 million days of lost productivity worldwide per year. Disaggregation 
of their results revealed that unemployed respondents had a higher prevalence of ADHD 
(5.5%) than working people (3.5%).  ADHD rates were associated with lower incomes 
and more blue-collar jobs than professional designations, along with appearing to be 
somewhat more prevalent in developed than developing countries.  The authors 
speculated the data could reflect the fact that a deficit is defined in relation to the level of 




excess of the person’s abilities. High environmental demands for attentiveness are more 
common in the workplaces of developed countries, leading to the higher recognition of 
adult ADHD in those countries (De Graaf et al, 2008). ADHD is associated with a 
significant decrease in role performance. Much of the decrease in role performance was 
noted in the areas of quality and/or quantity of work as opposed to an individual not 
being at work.  Adverse effects of ADHD were noted to be widespread, rather than 
concentrated among workers in jobs where high concentration is critical for success. The 
decreased quality and/or quantity of work for those with ADHD was noted to be an area 
for further research.  Decreased work-performance may increase workplace screening for 
ADHD. 
Effects of ADHD on the Family 
Evidence obtained by Johnston and Mash (2001) suggests that ADHD in children 
is associated with disturbances in family and marital functioning, disrupted parent-child 
relationships, and specific patterns of parental cognitions about child behavior and 
reduced parenting self-efficacy, along with increased levels of parenting stress and 
parental psychopathology.  The authors found that the rates of these issues increased 
when ADHD is present in addition to conduct disorders. Currently, there is little 
scientific data about the developmental mechanisms through which child and family 
characteristics develop in association with this diagnosis (Johnston and Mas, 2001).   
Szatmari et al. (1989) completed the Ontario Child Health Study of prevalence of 
attention deficit disorder with hyperactivity, which showed that siblings of children with 
ADHD have increased risk for emotional disorders. Kendall (1999) reported that siblings 




three primary ways: victimization, caretaking, sorrow and loss.  Siblings reported 
aggressive acts including verbal aggression, physical violence, manipulation and control 
from the child with ADHD (Kendall, 1999).  Researchers also found that siblings of 
children with ADHD felt anxious, worried, and sad because of household disruptions and 
the feeling that they had to care for and protect their sibling. Siblings in Kendall’s study 
described their family life as “chaotic”, “exhausting”, and “focused on their sibling”. 
Siblings described “never knowing what to expect next” and that they did not expect an 
end point to the impact of ADHD on their lives. Many siblings reported feeling 
unprotected by their parents because they were perceived as too exhausted or 
overwhelmed to intervene.  
As previously stated, ADHD imposes a significant financial burden regarding the 
cost of medical care and work loss for patients and family members. The increased use of 
health services is noted in relatives of individuals with ADHD resulting in direct and 
indirect medical costs that are twice as high as those of family members of a control 
group (Swensen, Birnbaum, and Secnik, et al. 2003).  Another issue noted in the 
literature was children with established ADHD are more likely to be injured as 
pedestrians or on a bicycle than children without ADHD and are more likely than other 
children to have severe injuries resulting from the accidents (Sullivan and Rudnik-Levin, 
2001).  Despite the increased rates of physical injury, Hankin (2001) found the major 
difference in costs was primarily noted to be due to a higher rate of mental health 
problems in family members of ADHD patients.  This increase reflects the increased 




increased risk of parental depression and alcohol disorders (Brown and Pacini, 1989 & 
Hankin, 2001).  
 Lack of Knowledge/Comfort with ADHD 
 Lack of knowledge and comfort are reported barriers to patient access for 
management of ADHD.  “The American Academy of Pediatrics (AAP) acknowledges 
that some primary care clinicians might not be confident of their ability to successfully 
diagnose and treat ADHD in a child because of the child’s age, coexisting conditions, or 
other concerns” (AAP, 2011, About This Guideline, note).  They go on to recommend 
that if a provider feels inadequate in providing care that a referral to a specialist is 
recommended. 
The statement that providers who feel inadequate providing care for ADHD 
should refer to a specialist, is made as part of the CPG put forth by the AAP.  The 
statement summarizes the lack of comfort many PCPs report with the management of 
ADHD.  “The expanding role of PCPs in this new era of mental health treatment has 
prompted researchers to explore ways of improving PCPs' training in diagnosing and 
treating psychiatric disorders” (Faghri et al. 2010, para 6).  Education for PCPs is 
indicated in this ever-growing area of healthcare. Marciano et al. (2012), completed a 
targeted educational program directed with the goal of improving physicians comfort 
levels when treating psychiatric patients in the emergency department.  Providers 
participated in a short educational program after which there was a highly significant 
improvement of comfort level noted (Marciano, 2012).  This data shows the positive 





A study by Pidano (2007) of primary care providers in British Columbia noted, 
“Physicians’ reported comfort and skill levels with evaluation and management were 
highest for mood disorders and lowest for behavior disorders. Comfort and skill levels 
were related to factors such as recent participation in continuing medical education 
regarding psychosocial issues and numbers of children with the conditions who were seen 
each month” (Pidano, 2007, p. 3). According to Charach, & Fernandez (2013), “Children 
diagnosed by psychiatrists are less likely to receive a prescription within the initial six 
months after diagnosis than those identified by primary care physicians, even after 
adjustment for comorbid conditions. Psychiatrists are more likely to provide titration of 
stimulant doses with a lower initial dose, a higher maximal dose, and three or more visits 
in the first 90 days, suggesting increased monitoring” (Patterns of Medication Use, para. 
2). 
This variance in care needs to be addressed to ensure patients are receiving the 
best care possible.  “Treating mental health patients in an already busy and stressful 
healthcare industry presents additional time management and treatment challenges for 
PCPs. To help improve the assessment of psychiatric conditions, physicians need a tool 
that is sufficiently uncomplicated and comfortable for their patients to complete, while 
still being easy and quick to interpret” (Faghri et al. 2010, para. 21). There are algorithms 
in place to help streamline the process for diagnosis and management of ADHD.  
Providers and parents must both understand that while methods to ensure a timely 
diagnosis are needed, this is not a diagnosis that can be made in a quick fifteen minute 
visit.  Informing patients and their caregivers of the process of diagnosis is one of the 




accurate diagnosis of ADHD is cited by many providers as a barrier to care along with 
lack of reimbursement (Leslie, 2002).   
Shortage of Providers 
 There is a notable healthcare shortage in the United States.  According to HRSA 
(2015), this shortage is even more notable in rural communities and in specialty areas 
such as pediatrics and psychiatrics.  According to Rainer (2014), “Sixteen percent of the 
United States' population lives in rural communities. Congressional reports find that these 
rural areas have less than one-half as many physicians per capita as urban areas” (Rainer, 
2014, para 4).  The US Department of Health and Human Services (HHS) and its Health 
Resources and Services Administration (HRSA) state that ninety million residents live in 
designated Mental Health Professional Shortage Areas (MHPSAs) (2015).  
Shortage areas are identified more frequently in rural and non-metropolitan areas. 
Mental health is an area of need across the United States and is more notable in rural 
areas due to the aforementioned shortage of all providers. Mental health services are 
needed for all age populations but most notably for pediatric patients in relation to 
ADHD.  “Physician demand is expected to increase seventeen percent and demand for 
physicians will exceed supply by a range of 46,000 to 90,000 by the year 2025” (AAMC, 
2015, para. 4).  According to the Bureau of Labor and Statistics (2015), there were 
122,050 nurse practitioners in 2014.  This portion of the health care team has the 
opportunity to positively affect health care in many ways. Many sources, including the 
National Institute for Healthcare (2013) reform, cite nurse practitioners as one of the 






Stimulant medications are the first line of treatment for pediatric patients ages 12-
18 and the strongest rated pharmacological treatment in all pediatric age groups (AAP, 
2011). Stimulants work by increasing the dopamine hormone levels in the brain.  The 
neurotransmitter dopamine is associated with pleasure, movement, and attention. 
Therapeutic effects of stimulant medications happen because of the slow and steady 
release of dopamine.  This mimics the way that dopamine is naturally produced and 
released into the brain (NIDA, 2014). When stimulant medications are taken in doses 
other than that prescribed and/or by routes other than orally, prescription stimulants can 
increase brain dopamine in a rapid and highly amplified manner.  This results in euphoria 
and increases the risk for addiction (NIDA, 2014).  Stimulant medications may be abused 
for the purpose of obtaining that feeling of euphoria.  
In a survey of more than 40,000 individuals nationwide, Johnston et al. (2015) 
found no gender differences in the overall associations between stimulant medication 
therapy for ADHD and risk of substance use. The study also identified these data points: 
approximately one in eight high school seniors have used stimulant or non-stimulant 
medication therapy for ADHD and stimulant medication is more likely to be used for 
males to treat ADHD; while no gender differences were found for non-stimulant 
medications (Johnston, et al., 2015).  
Because higher substance-use behaviors being associated with later initiation of 
stimulant medications monitoring new teen and adult patients carefully for pre-existing 
risk factors or the onset of substance use behaviors is very important (McCabe, Veliz, & 




with continuing ADHD symptoms have a substance-use disorder (McCabe et al., 2016).  
ADHD appears to represent an independent risk factor for substance abuse. McCabe et al. 
(2016) found that the presence of ADHD may affect the course of adolescent substance 
abuse in several ways: predicting earlier age of onset, longer duration of substance-use 
disorder, and progression of alcohol abuse to another drug-use disorder. Sullivan and 
Rudnik-Levin (2001) found that individuals with ADHD have been noted to have a 
shorter interval between the onsets of drug abuse and drug dependence. Such individuals 
are also at greater risk for treatment failure, as their disruptive behaviors interfere with 
treatment access and response (Sullivan and Rudnik-Levin, 2001).   
Prescription drug abuse is the nation’s fastest growing drug problem with more 
deaths occurring in the US last year due to drug overdoses than car accidents (CDC, 
2015).  Opiate addiction is driving this epidemic but diversion of any prescription 
medication helps pave the way to use of other drugs (CDC, 2015). The Clinton 
Foundation (2014) reports that the prescription drug use epidemic is widespread on 
college campuses with the proportion of college students using prescription drugs going 
up dramatically from 1993-2005. The use of opioids such as Vicodin, OxyContin, and 
Percocet increased by 343 percent, and use of stimulants like Ritalin or Adderall 
increased by 93 percent (Clinton Foundation, 2014).  
 Garnier, et al. (2010) completed a study of college students with ADHD, which 
was published in the Journal of Addictive Diseases and revealed that an alarming 62 
percent diverted their medication to someone without a prescription. According to the 
authors, most college students who use prescription medications non-medically 




regarding legal and medical consequences of diversion and how these perceptions 
influence behavior (Garnier, et al. 2010).  The authors found that almost two-thirds 
(61.8%) of college students were offered prescription stimulants for nonmedical use by 
their fourth year in college.  Again, the most common source was a friend with a 
prescription.  Lower GPA and alcohol/cannabis use disorders were consistently 
associated with non-prescription stimulant use (Garnier, et al. 2010). 
An ongoing study at the University of Maryland has reported that, 10.8 percent of 
students nationwide have used prescription stimulants in nonmedical situations over the 
past year and 35.6 percent of students surveyed have used them at least once in their 
lifetime (Garnier-Dykstra, et al., 2012).   The Drug Abuse Warning Network (DAWN) is 
a public health surveillance system that monitors drug-related emergency department 
visits in the United States.  The report involving ADHD stimulant medications, includes:  
methylphenidate (e.g., Ritalin, Concerta), amphetamine-dextroamphetamine (e.g., 
Adderall), dexmethylphenidate (e.g., Focalin), and dextroamphetamine (e.g., Dexedrine). 
The estimated number of emergency department visits involving the use of prescription 
stimulants to treat ADHD has increased among those aged 18 and older from 13,379 ED 
visits in 2005 to 31,244 visits in 2010.  Emergency department visits for nonmedical use 
has not increased among children and adolescents; however there has been an increase 
for adults aged 18 or older. These findings indicate a need for increased prevention of 







Practice Change Guidelines 
Best Practice Guideline 
The AAP’s CPG provides the foundation for the educational program, as well as 
the questions for the pretest and posttest. The Patient-Intervention-Comparison-Outcome-
Timeframe (PICOT) format recommended by Fineout-Overholt and Johnston (2005) was 
used to develop the following questions for searching the literature for an applicable 
CPG: What are the best methods for ADHD diagnosis? What are the best methods for 
evaluation of ADHD? What are the recommendations for treatment after diagnosis?  A 
search of the National Guidelines Clearinghouse (NGC), Registered Nurse Association of 
Ontario (RNAO), Agency for Healthcare Research and Quality (AHRQ) and Institute for 
Healthcare Improvement (IHI) websites was conducted searching for utilized and 
recommended practice guidelines for ADHD.  Through this search the American 
Academy of Pediatrics “ADHD: Clinical Practice Guideline for the Diagnosis, 
Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and 
Adolescents” (American Academy of Pediatrics, 2011) CPG was identified for 
evaluation. This CPG was written by a committee of members including: pediatricians, 
psychiatrists, parents and teachers.  This CPG seems to be the standard of care as it is 
referenced by other sources including: Centers for Disease Control and prevention, 
Cincinnati Children’s Hospital and Children’s Mercy Pediatric Care Network.   
The AGREE II instrument was used to appraise the quality of the CPG (AGREE 
Next Steps Consortium, 2009). According to the National Collaborating Centre for 
Methods and Tools (2011), this instrument assesses the rigor of a CPG’s development. 




Collaboration (Appraisal of Guidelines, Research and Evaluation), was established to 
develop this tool.  The purpose of the AGREE II Instrument is to provide a framework to: 
assess the quality of guidelines; provide a methodological strategy for the development of 
guidelines; and inform what information and how the information ought to be reported in 
guidelines. The AGREE II instrument consists of 22 key items separated into 6 domains.  
Each item is graded on a Likert scale ranging in score from 4-1(strongly recommend, 
recommend, would not recommend, and unsure). The six domains are: 1) Scope and 
purpose, 2) Stakeholder involvement 3) Rigor of development, 4) Clarity and 
presentation, 5) Applicability and 6) Editorial independence. Domain scores are 
calculated by summing up all the scores of the individual items in a domain and by 
standardizing the total as a percentage of the maximum possible score for that domain. 
The CPG was also evaluated using a rating scheme.  The method utilized was the 
Grading of Recommendations Assessment, Development and Evaluation (GRADE) 
system. Evaluation identified this CPG as one with strong recommendations and strength 
of evidence and also one that was well suited for use by primary care providers. This 
CPG contained six key action statements. Recommendations 1-4 and 6 are all rated 
Quality of Evidence B (strong recommendation). The fifth key action statement has three 
subsets relative to the patient’s age resulting in three ratings. Preschool aged children 
(ages 4-5) rating of B (strong recommendation), rating of A (strong recommendation) for 
school aged children (6-11) and a rating of C (recommendation) for adolescents (ages 12-
18). Only one of the recommendations, number 5, has an A rating when being applied to 
a school aged patient. However, all 6 practice recommendations have a rating of strong 




recommendations have the strongest level of evidence (strong recommendation). Overall, 
the evidence is strong. 6/6 (100%) strong recommendations for practice in patient’s ages 
4-11. 5/6 (83%) strong and 1/6 moderate (17%) recommendations for practice in patients 
ages 12-18. 
The following is a breakdown of strengths and weaknesses for the AAP CPG: 
Summary of Strengths and Weaknesses 
Strengths: 
 Clarity of scope and purpose of the document (Domain 1) 
 Population was well defined (Domain 1) 
 Objective is specific and targeted (Domain 1) 
 Subcommittee including relevant professional groups (Domain 2) 
 Target users were clearly identified (Domain 2)  
 Systemic methods were used to retrieve evidence (Domain 3) 
 Seventy references were utilized and reviewed using the GRADE method 
((Domain 3) 
 Key recommendations are easily identifiable (Domain 4) 
 Good supporting tools for implementation (Domain 5) 
 Financial conflicts were clearly stated and potential conflicts were identified 
(Domain 6) 
Mixed: 
  Explanation of facilitators and barrier (Domain 3) 
 No discussion on diet, herbal remedies, caffeine, or other natural management 
(Domain 4) 





 Criteria for selecting the evidence was not clearly described (Domain 3) 
 Methods for cost identification was not identified (Domain 5) 
 Applicability to practice for this guideline is noted to be very good in the area of 
tools, algorithms and methods for implementation.  The guideline was found to be 
lacking in its ability to identify barriers for implementation. Barriers identified in health 
care settings include: access to mental health services, unsupportive school districts, 
social stigma of diagnosis, and access to providers comfortable with management of 
ADHD.  When considering the potential resource implications of applying the 
recommendations, the guideline does not address the cost of medication management.  
Each key recommendation does have a risk, benefit, cost listed but there is no 
information provided on how this information was obtained. 
The clinical practice guideline, “ADHD: Clinical Practice Guideline for the 
Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in 
Children and Adolescents,” is worth consideration for implementation at the clinical 
level.   This guideline has overall good ratings, tools to help with implementation, and 
it’s well designed with concise key recommendations. 
Practice Change Recommendations for Implementation 
“ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment 
of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents” by the 
American Academy of Pediatrics (2011), contains six primary recommendations.  One of 
these recommendations had three subsets for each patient age group.  All of the 
recommendations for practice have strong recommendations with the exception of 




five and has a recommendation rating only. The six key action statements from the 
American Academy of Pediatrics can be located on their website and are identified within 
the implementation plan (Appendix A). 
Assessment Algorithm 
 The AAP offers an algorithm to coincide with their CPG (Appendix B).  
According to the AAP, “The algorithm is entirely consistent with the practice guideline 
and is based on the practical experience and advice of clinicians experienced in the 
diagnosis and management of ADHD in children and adolescents” (2011).  The steps of 
the algorithm are meant to increase the speed at which a provider can review the practice 
guidelines.  The detail provided within the algorithm is minimal and therefore does not 
have the same level of evidence as the key action statements that are provided in the 
practice guideline. The algorithm states an assumption that mental health surveillance and 
screening as entailed in the AAP Task Force on Mental Health has been adopted at the 
primary care practice level. They go on to state, “In light of the prevalence of ADHD, the 
severity of the consequences of untreated ADHD, and the availability of effective 
treatments for ADHD, the AAP recommends that every child/adolescent identified with 
signs or symptoms suggestive of ADHD be evaluated for ADHD” (2011). For an 
evaluation of every child/adolescent with a potential diagnosis of ADHD to occur, a 
primary care provider must have a knowledge base to identify this diagnosis and proceed 
with care as needed. 
 When information from the CPG and the algorithm are combined, ADHD can be 
assessed appropriately and in a time-effective manner.  All pediatric patients with ADHD 




referrals made as indicated.  Information for diagnosis or exclusion of diagnosis can be 
obtained from parents/guardians, teachers, and the patient based on action statements 2 
and 3 in the CPG. 
Summary  
Effective evaluation, diagnosis, and treatment of ADHD is a multistep process 
that involves many members of the patient’s health care team.  Providers must screen for 
this process but require information from the patient, parent/caregivers and 
teachers.  Assessments need to be completed at each of these levels to provide an 
accurate diagnosis.  When a diagnosis is made, treatment using behavioral therapies 
and/or medications require the cooperation of all the aforementioned parties.  During 
ongoing management, communication with all of these individuals is still 
needed.  Providers often lack the time to accomplish this in a primary care clinic. Chapter 
III details the methodology of this project including an initial online survey and a 


























This chapter discusses the research design for the study. It also describes the 
sample, instrument used and statistical analysis. Due to the increasing rates of ADHD and 
the healthcare shortage, methods to improve access to care are needed.  The method 
utilized in this project is education.  The goal of this project was to improve the 
knowledge of providers with pediatric ADHD patients. 
Project Design 
This is a two part study designed to evaluate whether an increase in knowledge of 
providers with Clinical Practice Guidelines (CPGs) for Attention Deficit Hyperactivity 
Disorder (ADHD) occurred after education was provided.  A separate online survey 
(Appendix C) was administered to primary care nurse practitioners to determine current 
knowledge level in regards to pediatric ADHD. This survey was placed on the 4-State 
Advanced Practice Nurses (APN) website approximately four weeks prior to the 
educational intervention to evaluate current knowledge and comfort levels of providers 
and was utilized as an additional method to assess the need for provider education.  This 
survey included demographic data, current acceptance of pediatric ADHD patients, 
comfort level with evaluation, diagnosis and management of ADHD and knowledge of 




When participants attended the educational intervention, a pretest was 
administered which included demographic data collection.  This data was utilized to 
determine any variability based on characterization of the group and to evaluate inclusion 
and exclusion criteria. The study used quantitative data for measurements of the 
participant’s knowledge with diagnostic criteria based on current practice guidelines. 
Descriptive research was chosen as it is a direct method to assess how ADHD is managed 
by primary care nurse practitioners. For pre-education results, data was obtained using a 
pretest (Appendix D).  For post education results data was obtained using a posttest 
(Appendix E).  A pretest/posttest application was chosen for the educational intervention 
of this study due to feasibility and time constraints. The study will provide valuable data 
in regards to participants and current practice guidelines.  The posttest contained the same 
questions as the pretest in regards to knowledge of ADHD. The educational intervention 
was presented to the participants and was then followed by a question and answer period.  
With completion of the education and posttest, one continuing education credit was 
awarded by the American Academy of Nurse Practitioners (AANP). 
The study provided an educational intervention to nurse practitioners and nurse 
practitioner students.  Prior to the educational intervention being provided, an online 
survey was provided to primary care nurse practitioners to determine their comfort level 
and knowledge of pediatric ADHD management.  Members of the 4-State APN group 
were invited to complete the initial survey and attend the separate educational 
intervention.  No information was obtained to determine if any individuals completed 




participants’ knowledge about evaluation, treatment, and diagnosis of pediatric ADHD 
patients after the program.  The study focused on the following research questions:  
1. Will an education intervention increase the knowledge of primary care providers 
when identifying diagnostic criteria that is based on current practice guidelines 
for pediatric ADHD? 
2. Will an education intervention increase the knowledge of primary care providers 
when selecting appropriate treatment for children based on current practice 
guidelines for pediatric ADHD? 
3. Will an education intervention increase the primary care providers’ knowledge of 
the AAP algorithm and its components? 
Setting and Participants 
The study participants included nurse practitioners and nurse practitioner students.  
All participants including students were able to listen to the educational portion of the 
educational intervention.  The pretest and posttest were only completed by current 
licensed nurse practitioners.  The participants were required to have a valid advanced 
practice license. The age of the participant was not identified although the number of 
years in practice was requested due to assessment of knowledge and comfort in a practice 
area. It is important to assess the current knowledge and comfort level of the providers 
for evaluation, diagnosis and treatment of ADHD, in order to increase access, appropriate 
identification and treatment. The educational intervention took place October 6th, 2016, in 
Pittsburg, Kansas, at a centrally located building that was easily accessible for all 
participants. The geographic location was chosen to encourage surrounding nurse 





 The study utilized a purposive sample; this was chosen because purposive 
sampling focuses on particular characteristics of a population that best enables the 
research questions (Purposive Sampling, 2012). The target population was recruited from 
the 4-State APN nurse practitioner group and from surrounding family practice clinics. 
The 4-State APN is a local professional group with over 100 members.  This group 
strives to provide education to local advanced practice nurses with multiple meetings 
throughout the year and an annual continuing education conference. Permission was 
obtained from the 4-State APN to invite their members to 1 hour educational program 
that was approved by the AANP. All advanced practice nurses in attendance received 
continuing education credit. Participation in the study included completion of the pretest 
and posttest. 
Inclusion/Exclusion Criteria 
 The initial online survey was accessible by all members of the 4-State APN 
group. Initial online survey data was only included for those providers currently 
practicing in primary care and accepting pediatric patients. Inclusion criteria for the 
pretest/posttest portion of educational intervention included all nurse practitioner 
participants present.  
 The 4-State APN has members that are nurse practitioner students; since they do 
not currently practice they were not included in the initial survey. Any other attendees 
including: medical doctors, doctors of osteopathy, clinical nurse specialist or physician 





Protection of Human Subjects 
Prior to distribution of the initial online survey or the educational intervention 
including the pretest and posttest, an application was submitted to the Pittsburg State 
University Institution Review Board (IRB).  The 4-State APN group does not have a 
formal IRB, but approval was granted from the 2016 presiding officers. The subject 
population is adult nurse practitioners over the age of 18. It does not contain vulnerable 
subjects; children, prisoners, or specific populations of race, religion or ethnicity. No 
deception of subjects took place nor were techniques used that would cause discomfort or 
harassment. Confidentiality was maintained with coding of the questionnaires. There 
were no risks associated with the study questionnaire. The responses of the subjects were 
not disclosed outside the research that could reasonably place them at risk of criminal or 
civil liability or be damaging to their financial standing, employability or reputation.  
Data was obtained for this study through participants volunteering for the study. 
Participants completing the initial survey, pretest and posttest provided consent for the 
study. The educational intervention was voluntary in nature with no monetary 
compensation provided to participants. Confidentiality was maintained regarding all 
information obtained from the pretest and posttest. The data was utilized for the purpose 
of this research. Information collected contained no identifying factors of the participants. 
Completed questionnaires were kept in a locked box accessible only by the primary 
investigator and were shredded at the completion of the project. 
Ethical Considerations 
Ethical considerations centered on the questionnaire development as well as the 




intervention with pretest and posttest was voluntary.  Participants were allowed to 
remove themselves from the study at any time without fear of reprisal.  The most notable 
ethical concern was anonymity. For this reason, information was recorded and stored 
without any identifying data. The second concern is the false information that would 
contaminate data and depart from study guidelines. The ethical concern would be the 
participant(s) fabricating all or part of the answers or providing information that is not 
consistent with their current knowledge or comfort in practice.  
Instrument 
This study utilized an initial online survey.  This survey included demographic 
data as well as questions about current practice, knowledge and comfort level with 
pediatric ADHD.  For the educational intervention, a pen and paper pretest and posttest 
were utilized by participants to gather quantitative data for descriptive study of the 
research questions. The pretest included demographic data about the participant 
including: area of practice, years in practice, state in which the participant is currently 
practicing, and their current acceptance of ADHD patients.  The pretest and posttest 
contained general knowledge-based multiple choice questions in regards to ADHD 
management. The pretest and posttest contained the same questions about provider 
knowledge with ADHD and CPGs. The demographic and current practice questions were 
removed from the posttest.    
An instrument specific to the research questions was not identified so a survey 
tool was developed. The instrument was developed based on review of current literature 
and information from the American Academy of Pediatrics CPG. The first four questions 




practice, followed by questions based on the CPG. The test had a variety of questions 
including multiple choice and rating scales.  The pretest was comprised of three major 
sections: (a) demographics, (b) current provider practice and (c) current practice 
guidelines. The posttest had one section: current practice guidelines.   
Content Validity   
The researcher’s developed tool for this study was based on a literature review. 
The review of literature was performed in an effort to validate the need for education of 
providers on ADHD with this researcher finding that providers lack a comfort level in 
treating pediatric patients with ADHD.  Content validity of the tool was established by an 
evaluation of the survey content.  Four family nurse practitioners who treat pediatric 
patients for ADHD in a family practice setting reviewed the pretest and posttest and 
scored it according to its relevance, clarity, organization and completeness with relation 
to current practice guidelines for ADHD. The scoring index was measured on a 1-4 
Likert scale, with 1=not relevant, 2=somewhat relevant, 3=quite relevant and 4=very 
relevant. Each provider scored the questions and provided comments and concerns for 
review.  Suggestions were obtained from each reviewer.  All recommendations were 
considered and the test was then modified to improve content, readability and clarity of 
the questions. After the questions were approved by the practicing nurse practitioners, the 
primary investigator had three nurse practitioner students complete the test. The pretest 
was the lengthiest of the questionnaires and was administered to asses for clarity and to 
detect if survey fatigue is a concern. The pretest took the nurse practitioner students 
between 10-15 minutes to complete. Survey fatigue and comprehension were not noted as 





The project consisted of an initial survey and an educational presentation over 
current clinical practice guidelines related to ADHD. Consent was implied by participants 
who completed the initial survey and/or attended the educational intervention and 
submitted the pretest and posttest.  With permission from the 4-State APN group, emails 
were sent to their members with a link to an initial online survey on pediatric ADHD.  
The link was also posted on the 4-State APN Facebook page.  Participants were 
instructed to complete the initial online survey one time only. Completion of the online 
survey provided consent to utilize the data.  The data from the online survey was obtained 
and reviewed by the researcher.  Members of the 4-State APN were invited to participate 
in a free one hour continuing education intervention approved by the AANP.  The online 
survey was closed prior to the educational intervention.   
Before beginning the educational intervention, the study’s purpose was explained 
followed by an opportunity for questions.  Participants that chose not to participate 
simply did not complete the packet, but were encouraged to stay for the continuing 
education unit. Packets consisting of the pretest and posttest were handed out to the 
appropriate participants. Instructions were provided not to open the packet until the 
project was explained and all questions are answered.  Completion of the pretest and 
posttest were completely voluntary; participants at the program received continuing 
education credit regardless of inclusion in the study. The pretest was completed and 
returned to the packet prior to the beginning of the PowerPoint presentation. The 
educational intervention lasted approximately 30-45 minutes. When the PowerPoint 




the willing participants. Participants were then directed to return the posttest to their 
packet.  Then, the packets were collected and placed in a lockbox. When all packets were 
returned, participants were allowed time for a question and answer session.   
Demographic data was collected from four questions on the online survey. The 
same four questions were utilized for demographic information on the pretest to describe 
characteristics of participants.  Data from the initial online survey was obtained and 
accessible only by the researcher. Pretests and posttests were collected by the researcher 
and secured in a locked box only accessible by the researcher. Data from the initial 
survey was utilized to assess the current population of nurse practitioners.  Statistical 
analysis was performed on the pretest and posttest utilizing an Excel spreadsheet to 
tabulate data collected.   
Summary 
The rates of ADHD indicate a need for providers to be comfortable with 
management and have a good knowledge base on current CPGs. There is a need for an 
educational intervention on ADHD with current guidelines and tools to assist providers in 
accurately following recommendations and improving their comfort managing this 
condition. According to Harkins et al, (2012) if providers are aware of the guidelines, the 
more likely they are to use them.  This project included an initial survey to determine 
providers’ current practices with ADHD.  Then the study provided an educational 
program to participants with a pretest to evaluate current knowledge followed by a 
posttest to evaluate knowledge gained from the program.  Chapter IV discusses the 




















The data in this study was collected to determine whether an increase in 
knowledge would occur when providers were provided education on the current clinical 
practice guidelines for pediatric ADHD.  The first sample had 26 participants who 
completed an online survey for nurse practitioners. The second sample included 20 total 
participants at a local setting for continuing education units.  The participants were all 
nurse practitioners with valid current licensure. The first data set offered information on 
provider comfort and knowledge in regards to pediatric ADHD prior to any intervention.  
The second data set analysis will show if education improved knowledge on ADHD 
CPGs.  
Demographic Data 
The demographic data collected from the participants included area of practice, 
years of practice as a nurse practitioner, state in which they are currently practicing, and 
whether they currently diagnosis and treat ADHD or not.  This data is presented in Table 





Of those participating in the initial online survey sixty-five percent of participants 
(n=17) are in the family practice setting and care for children and 34% (9) reported their 
specialty as other. Nineteen percent of providers (n=5), have been in practice for 0-3 
years, followed by 23% (n=6) at 3-5 years, 23% (n=6) at 5-10 years, 34% (n=9) at 10-20 
years, no participants reported greater than 20 years in practice. Sixty-five percent (n=17) 
of the participants reported currently diagnosing and treating pediatric patients with 
ADHD. Eighty-four percent (n=22) of the participants reported not following any specific 
clinical practice guideline for ADHD.  Forty-two percent (n=11) of participants reported 
being uncomfortable or very uncomfortable with diagnosing ADHD. Ninety-two percent 
(n=24) of the providers surveyed felt they would benefit from further education on the 
evaluation, diagnosis and treatment of ADHD. 















Table 2. Pretest/Posttest Demographic Data 
 
Pretest and Posttest 
All participants were given a pretest immediately prior to the educational 
intervention and a posttest immediately following the intervention. The tests were 
anonymous and only identified by a number. Both tests contained the same 20 questions 
and were worth 20 total points. Nineteen of the questions were multiple choice with one 
select all that apply question.  The questions were focused on assessment, diagnosis and 
treatment of pediatric ADHD. Ten of the pretest and posttest questions were in relation to 
knowledge of current clinical practice guidelines.  Seven questions on the pretest and 
posttest were about selecting appropriate treatment for pediatric ADHD.  Ten questions 

















Results of the Study 
 
 The pretest scores ranged from 0-12 correct answers. Only one participant did not 
get any correct answers on the pretest and only one participant was scored as 12 correct 
with the majority of the scores falling in between. The mean pretest score was 7.8 with a 
standard deviation of 4.12 in the pretest group (n=20). The posttest scores ranged from 
10-19 correct answers. Three participants answered 19 out of 20 questions correct and 
scored 95% on the posttest. The mean posttest score was 16.4 with a standard deviation 
of 3.9 in the posttest group (n=20). The differences in pretest and posttest scores had a 
median of 8.7 (n=20). All respondents (n=20) had an increase in posttest scores after the 
education was provided as evidenced by Table 3.  
Participants answered more questions correctly after the educational intervention 
in relation to each of the research questions. Tables 3-11 will display the pretest answers 
compared to the posttest answers as they relate to each research question. The study 
concluded with substantial statistical significance (p<0.001) that the education provided 
an increase in the posttest score from the pretest score of the providers with current CPGs 
on pediatric ADHD. In relation to the research question the study showed a significant 
increase (t(9)=-10.48, p<0.001) in the post-test scores (M=16.3, SD=13.57) over the pre-
test scores (M=7.4, SD=15.38) in  the participant's ability to identify diagnostic criteria 
based on current practice guidelines for pediatric ADHD.  Participant's ability to select 
appropriate treatment based on current practice guidelines for pediatric ADHD showed a 
significant increase (t(6)=-7.12, p<0.001) in the post-test scores (M=17.14, SD=2.14) 
over the pre-test scores (M=6.85, SD=9.14). The study also showed a significant increase 




(M=7.3, SD=24.01) in relation to the primary care providers’ knowledge of the AAP 
algorithm and its components. 
Table 3. Pretest/Posttest Score Analysis  
 











































































































Mean 7.8 16.35 
Variance 17.01052632 15.18684211 
Observations 20 20 
Pearson Correlation 0.52524043   
Hypothesized Mean Difference 0   
df 19   
t Stat -9.771218666   
P(T<=t) one-tail 3.81545E-09   
t Critical one-tail 1.729132812   
P(T<=t) two-tail 7.63091E-09   
t Critical two-tail 2.093024054   
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Pretest/Posttest Results for Research Question #1 




Table 7: Pretest/Posttest Results for Research Question 1; t-Test: Paired Two Sample for 
Means 





Mean 7.4 16.3 
Variance 15.37777778 13.56666667 
Observations 10 10 
Pearson Correlation 0.752337965   
Hypothesized Mean Difference 0   
df 9   
t Stat -10.48066677   
P(T<=t) one-tail 1.20879E-06   
t Critical one-tail 1.833112933   
P(T<=t) two-tail 2.41758E-06   
t Critical two-tail 2.262157163   
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Table 9: Pretest/Posttest Results for Research Question 2; t-Test: Paired Two Sample for 
Means 





Mean 6.857142857 17.14286 
Variance 9.142857143 2.142857 
Observations 7 7 
Pearson Correlation -0.371160904   
Hypothesized Mean Difference 0   
df 6   
t Stat -7.129062309   
P(T<=t) one-tail 0.000191727   
t Critical one-tail 1.943180281   
P(T<=t) two-tail 0.000383455   
t Critical two-tail 2.446911851   
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Table 11: Pretest/Posttest Results for Research Question 3; t-Test: Paired Two Sample for 
Means 





Mean 7.3 15.5 
Variance 24.01111 24.5 
Observations 10 10 
Pearson Correlation 0.510791   
Hypothesized Mean Difference 0   
df 9   
t Stat -5.32273   
P(T<=t) one-tail 0.00024   
t Critical one-tail 1.833113   
P(T<=t) two-tail 0.000479   
t Critical two-tail 2.262157   
 
Analyzing individual questions that were most often answered incorrectly is 
important to determine content areas that may need reinforced through further education 
(Table 4). The most frequently missed questions on the pretest were numbers 4, 14 and 
19. Seventy-five percent (n=15) of participants incorrectly answered question number 17 
based on current clinical guidelines and the algorithm.  Question 17 asked, if a patient has 
symptoms of ADHD but does not meet diagnostic criteria what is the next step? The 
answers included: educate the parents on normal child behaviors, evaluate for another 
condition, refer for further psychological testing and schedule a follow-up to reassess.  
The answers varied among the participants.  The correct answer according to guidelines 
is to evaluate for another condition.  The score did not vary from the pretest to the 
posttest, but question 17 remained the most frequently missed question on both tests.  On 
the pretest 75% (n=15) answered the question incorrectly. On the posttest 75% (n=15) of 




wording of the question, multiple options discussed in the educational presentation, and 
participants believing more than one answer to be correct.  
This study indicates that many providers in family practice do not have a good 
knowledge of the current practice guidelines for pediatric ADHD. Improved scores were 
noted in all participants with the AAP pediatric clinical practice guideline and usage.  
Pretest scores ranged from 0-60% (n=1, n=1) correct.  Posttest scores ranged from 50-
95% (n=1, n=3).  The mean pretest score was 39% while the mean posttest score was 
82%. 
Summary 
 Chapter four discussed the statistical analysis of the pretest and posttest scores. A 
positive outcome evaluation was indicated by an increase (p<0.001) in correct answers 
after the educational program was completed.  Increased use of the guidelines and 
improved assessment and treatment are all linked to increased understanding and 
education of the current practice guidelines. The findings of the study support that many 
providers are not aware of the current clinical practice guidelines in ADHD. Although 
information is readily available through websites, guidelines, research and practice 
settings, providers must update their knowledge continuously, to improve assessment and 
treatment of children with ADHD. The findings validate the need for educational 
programs for providers on pediatric ADHD. Chapter 5 discusses future recommendations 






















The study obtained data from an online survey of nurse practitioners in regards to 
their knowledge and comfort level with ADHD.  The initial survey was followed by an 
educational intervention provided to nurse practitioners in order to evaluate whether an 
increase in knowledge occurred based on pre and posttest responses to specific indicators 
of pediatric ADHD. The testing challenged the providers’ knowledge and sought to 
evaluate if increased knowledge occurred after an educational intervention. The study 
focused on the following research questions:  
1.  Will an educational intervention increase the knowledge of primary care 
providers when identifying diagnostic criteria that is based on current practice 
guidelines for pediatric ADHD? 
2. Will an educational intervention increase the knowledge of primary care 
providers when selecting appropriate treatment for children based on current 
practice guidelines for pediatric ADHD? 
3. Will an educational intervention increase the primary care providers’ knowledge 





Relationships of Outcomes to Research 
 Increased Accuracy Identifying Diagnostic Criteria 
 The educational intervention increased (p<0.001) the knowledge of nurse 
practitioners when identifying diagnostic criteria that is based on CPGs for pediatric 
ADHD.  Prior to the educational intervention nurse practitioners answered pretest 
questions in relation to diagnostic criteria for pediatric ADHD accurately 37% of the 
time.  After the educational intervention participants answered posttest questions in 
regards to diagnostic criteria correctly 81.5% of the time.  Participants had an average 
increase of 44.5% from pretest to posttest.  
The pretest scores showed that nurse practitioners only answered questions in 
relation to diagnostic criteria correctly 37% of the time, which correlates with the need 
for PCP education in the areas of mental health noted in the research.  Faghri et al. (2010) 
reported that the expanding role of PCPs in mental health warrants improved education in 
diagnosing and treating psychiatric disorders. Education for PCPs is indicated in this 
ever-growing area of healthcare. 
 Increased Accuracy Selecting Appropriate Treatment 
 The educational intervention increased (p<0.001) the knowledge of nurse 
practitioners in regards to selecting appropriate treatment for pediatric ADHD based on 
current CPGs. Nurse Practitioners answered questions on the pretest in relation to 
treatment for pediatric ADHD accurately 34% of the time prior to an educational 
intervention.  After the intervention participants answered the same posttest questions 





The pretest scores correlate with research showing that primary care providers are 
not following current practice guidelines for ADHD treatment.  Charach and Fernandex 
(2013) reported that children diagnosed by primary care providers are more likely to 
receive a prescription ADHD medication in the first six months after diagnosis than those 
diagnosed by psychiatrists.  Psychiatrists are more likely to provide titration of stimulant 
medications and increased dosage monitoring over the first 90 days (Charach & 
Fernandex, 2013).  Many of the providers in this study chose on the pretest the non-
stimulant medications as their first therapy, despite stimulant medications being the first 
line of treatment for pediatric patients ages 12-18 and having the strongest rated 
pharmacological treatment in all pediatric age groups (AAP, 2011). This finding helped 
to support a need for education on treatment options in this population of primary care 
providers.   
Treatment of a condition with an addictive medication further validates the need 
for provider education. Substance-use behaviors increase with delayed initiation of 
stimulant medications, which makes monitoring for substance abuse very important 
(McCabe, Veliz, & Boyd, 2016). Prescription drug use is widespread at colleges across 
the United States and the misuse and abuse of stimulants has increased by 93 percent 
(Clinton Foundation: Editorial Team, 2014). Providers need education on proper 
treatment and monitoring of this chronic condition to help prevent addictive behaviors, 
medication diversion and abuse. 
 Increased Knowledge of the AAP Algorithm 
 Nurse practitioners showed an increased (p<0.001) knowledge of the AAP 




in relation to providers’ knowledge of the AAP algorithm and its components showed 
correct responses by nurse practitioners 36.5% of the time.  After education was 
provided, participants had average scores of 77.5% of correct responses on the same 
questions.  This data revealed an average participant score increase of 41%. 
Faghri et al. (2010) reported that treating mental health patients presents 
additional time management and treatment challenges for PCPs thus providers need a tool 
that is uncomplicated, easy and quick to interpret.  The AAP has created an algorithm to 
utilize when diagnosing and treating pediatric ADHD patients.  Providers must first know 
that the algorithm exists to utilize its functionality.  Lack of knowledge and comfort in 
regards to the CPG algorithm are reported barriers to patient access for management of 
ADHD.  When information from the CPG and the algorithm are combined ADHD can be 
assessed appropriately and in a time-effective manner.  The pretest scores validate the 
data found in research that more provider education and utilization of algorithms are 
needed. 
Observations 
Many observations can be made based on comparisons of the initial survey data, 
as well as, pretest and posttest data. Information from this study can also be compared to 
previous research and studies. Many of the studies reviewed were completed with larger 
populations with similar notable consistencies as found within this smaller study. The 
initial survey confirmed reports within the literature that providers are uncomfortable 
diagnosing and treating pediatric ADHD.   
The initial survey data showed that sixty-five percent of the participants were 




of participants were uncomfortable or very uncomfortable diagnosing ADHD.  The 
literature review showed a lack of knowledge and comfort as reported barriers to patient 
access for management of ADHD.  The findings from the initial survey agree with 
publications from the AAP acknowledging that primary care clinicians might not be 
confident in their ability to diagnosis and treat pediatric ADHD (2013). Ninety-two 
percent of the providers surveyed felt they would benefit from further education on the 
evaluation, diagnosis and treatment of ADHD. This result correlates with this 
researcher’s findings that stated providers treating psychiatric conditions reported the 
highest level of comfort treating mood disorders and lowest level of comfort for treating 
behavior disorders.  
Studies were reviewed that showed improved provider knowledge after 
educational interventions but no studies were found showing specific data in relation to 
pediatric ADHD.  Although this study was completed on a small scale, the results did 
document improvement of provider knowledge after education on pediatric ADHD and 
the clinical practice guidelines. 
Evaluation of Conceptual Framework 
The Health Promotion Model had positive influences and helped ensure an 
increase in knowledge regarding evaluation, diagnosis and treatment of pediatric ADHD. 
Pender’s Health Promotion Model (2011) was utilized as a basis for the research and 
provided a framework for integration of clinical practice guidelines and education using 
evidenced-based practice. Providers were educated on the AAP guidelines for diagnosis 




intervention modeled the expectations for ADHD evaluation and treatment and provided 
assistance through educational intervention to enable the behavior.   
The goal of this project was to provide assistance through education to increase the 
knowledge of providers in the treatment of pediatric ADHD.  Information on ADHD 
improved self-efficacy of nurse practitioners in relation to the treatment of ADHD. The 
CPG from the AAP with algorithm served as the plan of action for diagnosis and 
treatment of patients.  Education was provided to positively affect providers’ knowledge 
of pediatric ADHD.  Nurse practitioners who attended the educational intervention were 
actively seeking to regulate their behaviors in patient care.  The attendees interacted with 
their environment and had notable change from the educational intervention. Lastly, self-
initiated reconfiguration of the person-environment and the interactive patterns within is 
essential to changing behavior.  Reconfiguration was noted in the participants during this 
study as demonstrated by the study outcomes.  This study invoked a conscious effort to 
engage in health-promoting behaviors, modeled the expected behaviors within clinical 
practice, with an expectation that the behaviors would occur and most importantly 
provide the assistance and support to enable correct pediatric ADHD evaluation, 
diagnosis and treatment.  The integration of Pender’s Health Promotion model provided a 
guide to ensure improved knowledge of the CPG after the educational intervention.  
Limitations  
 One limitation of the study is the findings applied to the specific participants 
surveyed and may not be generalized to other populations. Members of the 4-State 
Advanced Practice nurses group were utilized as a convenience sample.  Most 




this study.  Also, since participants self-selected to participate in this study, the 
participants may have different ideas and experiences concerning the use of CPGs than 
those participants who may have chosen to not participate. Another limitation to the study 
was that all the participants were nurse practitioners (NP).  This aspect may limit the 
study findings to NPs from similar practice settings. 
Future Research 
The study findings suggest several areas for future research. A better 
understanding of the pediatric ADHD clinical practice guidelines is noted.  Even after 
education, participants were not able to correctly answer questions in regards to 
evaluation if the patient does not meet diagnostic criteria for ADHD.  One reason for this 
might be that providers often proceed with more than one method if a patient does not 
meet diagnostic criteria.  Research could continue on this project by assessing retention 
of provider knowledge three, six, nine and twelve months after the educational 
intervention.  Surveying participants further out from the educational date in order to 
evaluate whether the current evidenced-based clinical practice guidelines became a part 
of their daily clinical practice would provide useful information.  Data could also be 
obtained on the provider’s changes in regards to ADHD evaluation, diagnosis and 
treatment.   A follow-up study and educational program is needed to provide information 
to providers regarding ongoing management of ADHD and proper treatment adjustments 
as the patient ages.  
 Providers need a knowledge base of ADHD diagnostic criteria in order to practice 
safely and effectively.  Prior to the education, participants were only able to identify 




after the education, that does not ensure that improvement will be made in the clinical 
setting.  Research is needed on the long-term effects of education and methods for 
improving diagnosis.  Access to the algorithm within an electronic medical record (EMR) 
is an area of research that could increase accurate diagnosing and treatment.  The addition 
of CPGs and the AAP algorithm within an EMR would allow for quicker provider 
reference.  Research could then be completed to determine the EMR additions improve 
accuracy of diagnosis and treatment.  Access to educational information and patient 
assessments within a patient portal could also be reviewed.  Studies could be completed 
on effects of forms and questionnaires for ADHD diagnosis being accessible by parents 
and teachers electronically.  The completed forms could also be available in electronic 
format for providers to review prior to patient visits.  Reminders to monitor specific 
criteria, follow-up with teachers and completion of any needed testing could be available 
within an EMR. Future research could also include using self-reported answers and chart 
audits for an accurate evaluation of providers’ practice. 
Dissemination of Information  
The end result of this study was to provide knowledge and initiate a practice 
change based on the clinical practice guidelines. The information from the project can 
assist providers in following current practice recommendations which not only improves 
patient outcomes but can also help to reduce the overall healthcare burden of ADHD. 
Further education could be provided at future continuing education events including 
online and video presentations. 
This project was approved for 1.25 CE credits through the AANP providing 




articles. This study can be used to guide educational resources for providers in order to 
enhance knowledge of current clinical practice guidelines.  The educational intervention 
that was presented as part of this study could be recorded and made available to providers 
online.  Making this education available online would improve educational access and 
would allow providers from across the nation to review the information provided and 
would remove both geographical and time barriers.   
The need for diagnosis and treatment of mental health by family practice 
providers is projected to increase (CDC, 2015).  This calls for more education of family 
nurse practitioners prior to starting their clinical practices.  Educational institutions 
should consider a requirement of psychiatric content to be added into anatomy, 
pathophysiology and pharmacology courses.  Clinical opportunities with psychiatric 
providers actively diagnosing and treating patients would also be beneficial for nurse 
practitioner students.   
Policy briefs have the potential to reach influential legislators and increase 
opportunities for funding and programs aimed at increasing availability of mental health 
services for pediatric ADHD and comorbidities. Research studies can help to provide the 
information in support of education to increase provider knowledge of pediatric ADHD 
guidelines, thus potentially impacting the economic burden of this chronic disorder.  
Proper diagnosis and treatment are needed to ensure effective management of the 
disorder and to improve overall patient and family outcomes.  
Conclusion 
The purpose of this evidence-based research project was to confirm that providers 




awareness of the current Clinical Practice Guidelines and algorithms and to improve the 
knowledge of pediatric ADHD management in primary care providers. 
      The initial survey confirmed the barrier to treating ADHD that was found during 
the review of literature. Many nurse practitioners are not comfortable and do not feel they 
have the knowledge to diagnose and treat pediatric ADHD.  The findings within the 
initial survey helped to develop the chosen material provided in the educational 
intervention.  The participants were given the opportunity to learn about current practice 
guidelines on pediatric ADHD. The researcher’s hope is that this education will increase 
providers’ knowledge of ADHD and increase the number of primary care providers that 
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American Academy of Pediatric on ADHD 
Summary of key action statements:  
 
Key Action Statement Rating 
1. The primary care clinician should initiate an evaluation for 
ADHD for any child 4 through 18 years of age who presents 
with academic or behavioral problems and symptoms of 
inattention, hyperactivity, or impulsivity 
Quality of evidence B/strong 
recommendation. 
 
2. To make a diagnosis of ADHD, the primary care clinician 
should determine that Diagnostic and Statistical Manual of 
Mental Disorders, Fourth Edition criteria have been met 
(including documentation of impairment in more than 1 major 
setting); information should be obtained primarily from 
reports from parents or guardians, teachers, and other school 
and mental health clinicians involved in the child's care. The 
primary care clinician should also rule out any alternative 
cause  
Quality of evidence B/strong 
recommendation. 
 
3. In the evaluation of a child for ADHD, the primary care 
clinician should include assessment for other conditions that 
might coexist with ADHD, including emotional or behavioral 
(eg, anxiety, depressive, oppositional defiant, and conduct 
disorders), developmental (eg, learning and language disorders 
or other neurodevelopmental disorders), and physical (eg, tics, 
sleep apnea) conditions  
 
Quality of evidence B/strong 
recommendation. 
4. The primary care clinician should recognize ADHD as a 
chronic condition and, therefore, consider children and 
adolescents with ADHD as children and youth with special 
health care needs. Management of children and youth with 
special health care needs should follow the principles of the 
chronic care model and the medical home  
 
Quality of evidence B/strong 
recommendation. 
5. Recommendations for treatment of children and youth with 
ADHD vary depending on the patient's age:  





a. For preschool-aged children (4–5 years of age), the primary 
care clinician should prescribe evidence-based parent- and/or 
teacher-administered behavior therapy as the first line of 
treatment and may prescribe methylphenidate if the behavior 
interventions do not provide significant improvement and 
there is moderate-to-severe continuing disturbance in the 
child's function. In areas where evidence-based behavioral 
treatments are not available, the clinician needs to weigh the 
risks of starting medication at an early age against the harm of 
delaying diagnosis and treatment (quality of evidence 
B/recommendation). 
b. For elementary school–aged children (6–11 years of age), the 
primary care clinician should prescribe US Food and Drug 
Administration–approved medications for ADHD and/or 
evidence-based parent- and/or teacher-administered behavior 
therapy as treatment for ADHD, preferably both (quality of 
evidence B/strong recommendation). The evidence is 
particularly strong for stimulant medications and sufficient but 
less strong for atomoxetine, extended-release guanfacine, and 
extended-release clonidine (in that order) (quality of evidence 
A/strong recommendation). The school environment, program, 
or placement is a part of any treatment plan. 
c. For adolescents (12–18 years of age), the primary care 
clinician should prescribe Food and Drug Administration–
approved medications for ADHD with the assent of the 
adolescent and may prescribe behavior therapy as treatment 
for ADHD preferably both. 
b) Quality of evidence A/strong 
recommendation 
c) Quality of evidence 
C/recommendation 
6. The primary care clinician should titrate doses of medication 
for ADHD to achieve maximum benefit with minimum 
adverse effects  















Appendix C:  
Initial Survey 
Please complete the following survey.  Circle the appropriate response or fill in the 
blanks when applicable. 
 
1. What is your current area of Practice?  
Family Practice  
Other: _________ 
2. How many years have you practiced as a nurse practitioner? 
a. 0-3 years    
b. 3-5 years 
c. 5-10 years  
d.  10-20 years   
e. >20 years   
 
3. In what State are you currently practicing? 
a.  Missouri 
b.  Kansas  
c. Arkansas  
d. Oklahoma  
e. Other: _________ 
 
4.  Do you currently diagnosis and treat pediatric patients with ADHD? 
a.  Yes 
b. No 
If no, why not? (Select all that apply) 
Against Clinic Policy 
Agreement with collaborative Physician 
Uncomfortable providing diagnosis 
Uncomfortable prescribing stimulant medication  
Other: ___________ 
 
5. As a provider how would you rate your education and knowledge base to treat 
ADHD? 
Poor     Fair           Good          Very Good  Excellent      
 
6. Do you feel comfortable diagnosing ADHD? 
Very Uncomfortable  Uncomfortable    Neutral     Comfortable  Very 
Comfortable 
 
7. Please select which age groups you treat for ADHD.   






8. Do you follow any specific Clinical Practice Guideline when treating ADHD? 
Yes   No    
If yes, please list which Clinical Practice Guideline: ______________ 
 
9. Do you have a good knowledge base of current practice guidelines for the 
diagnosis and management of ADHD? 
Poor       Fair              Good          Very Good Excellent 
 
10. Do you feel comfortable using the American Academy of Pediatrics guideline for 
ADHD? 
Very Uncomfortable  Uncomfortable    Neutral     Comfortable  Very 
Comfortable 
 
11. Are all of your patients with a suspected diagnosis of ADHD referred to a 
specialist? 
Yes   No   
 
12. If so, to whom is the referral made? 
Another PCP  Pediatrician Psychiatrist Psychologist Other: 
___________  
 
13. What is the current wait time for patients who you refer to specialists for 




6-8 months  
> 8 months 
Other: _______ 
 
14. After referral to a specialist will you follow up on patients for ongoing 
management of ADHD? 
Yes   No   Not Applicable 
 
15. Rate your knowledge base for treatment options of ADHD? 
Poor     Fair           Good          Very Good Excellent 
 
16. For patients you treat with ADHD how often do you require follow up? 
1 month  3 months  6 months Yearly   Other: _________ 
 
17. Do you feel that primary care providers should diagnosis ADHD? 





18. Do you feel that primary care providers should treat ADHD? 
Yes   No   
 
 
19. Do you think you would benefit from further education on the evaluation, 
diagnosis and treatment of ADHD? 
Yes   No     
 
20. Would you like to receive education on the American Academy of Pediatrics CPG 
for ADHD? 
Yes   No   
 
21. Do you think there is a shortage of providers in your area who treat ADHD? 
Yes   No   
 
 



















Appendix D:  
Pretest 
Pretest 
Please complete the following pretest.  Circle the appropriate response or fill in the 
blanks when applicable. 
A. What is your current area of Practice?  
Family Practice  
Other: _________ 
B. How many years have you practiced as a nurse practitioner? 
f. 0-3 years    
g. 3-5 years 
h. 5-10 years  
i.  10-20 years   
j. >20 years   
 
C. In what State are you currently practicing? 
f.  Missouri 
g.  Kansas  
h. Arkansas  
i. Oklahoma  
j. Other: ___________ 
 
D.  Do you currently diagnosis and treat pediatric patients with ADHD? 
c.  Yes 
d. No 
If no, why not? (Select all that apply) 
Against Clinic Policy 
Agreement with collaborative Physician 
Uncomfortable providing diagnosis 
















1. Primary care providers can diagnosis ADHD. 
a. True 
b. False 
c. Only with additional training. 
 










4. To make a diagnosis of ADHD, the clinician provider needs to establish that at 
least ___ or more of the 9 core symptoms per dimension are present in either or 




















8. ADHD symptoms often appear between the ages of 
a. 0-3 years 
b. 3-6 years 






9. To be diagnosed with the ADHD, a child must have symptoms for __________ 
months and to a degree that is greater than other children of the same age. 
a. 3 or more 
b. 6 or more 
c. 9 or more 
d. 12 or more 
 
10. When a provider determines that management is needed for ADHD which of 
these has the strongest level of evidence for use? 
a. Extended release Guanfacine 
b. Extended release Clonidine 
c. Stimulant medications  
d. Behavioral therapy 
 
11. Stimulant medications are the first line of treatment for ADHD. 
a. True 
b. False 
c. Depends on age of the patient 
 
12. Studies have found a link between stimulant medication use for ADHD and 









14. Providers should refer suspected ADHD patients when ________ (select all that 
apply). 
a. Comorbid conditions exist 
b. Provider is uncomfortable making the diagnosis 
c. Patient’s diagnosis is not clear 
d. Request is made by the parents 
e. Patient is under 5 years of age 
f. Symptoms have been present for less than 6 months 
 
15. Patients with ADHD must be evaluated by a psychiatric provider ____________. 
a. At initial diagnosis 
b. At least once per year 
c. With any medication (not including dosage) change 





16. If a stimulant medication is initiated for ADHD and it does not seem to be helping 
the first action is to ________ 
a. Change to a non-stimulant medication  
b. Change to a different stimulant medication 
c. Increase the dose 
d. Re-evaluate ADHD diagnosis 
 
17. If a patient has symptoms of ADHD but does not meet diagnostic criteria the next 
step is to___________. 
a. Educate the parents on normal child behaviors 
b. Evaluate for another condition 
c. Refer for further psychological testing 
d. Schedule a follow-up to reassess 
 




19. Once a diagnosis of ADHD is established the patient needs follow up 
appointments at least ________. 
a. Every 3 months 




20. Which of these medications is recommended if pharmacotherapy is needed in a 5 
year old patient with ADHD? 
a. Guanfacine  
b. Amphetamines  
c. Methylphenidate 
d. Clonidine 













Please complete the following pretest.  Circle the appropriate response or fill in the 
blanks when applicable. 
 
1. Primary care providers can diagnosis ADHD. 
a. True 
b. False 
c. Only with additional training. 
 










4. To make a diagnosis of ADHD, the clinician provider needs to establish that at 
least ___ or more of the 9 core symptoms per dimension are present in either or 






















8. ADHD symptoms often appear between the ages of 
a. 0-3 years 
b. 3-6 years 
c. 6-9 years 
 
9. To be diagnosed with the ADHD, a child must have symptoms for __________ 
months and to a degree that is greater than other children of the same age. 
a. 3 or more 
b. 6 or more 
c. 9 or more 
d. 12 or more 
 
10. When a provider determines that management is needed for ADHD which of 
these has the strongest level of evidence for use? 
a. Extended release Guanfacine 
b. Extended release Clonidine 
c. Stimulant medications  
d. Behavioral therapy 
 
11. Stimulant medications are the first line of treatment for ADHD. 
a. True 
b. False 
c. Depends on age of the patient 
 
12. Studies have found a link between stimulant medication use for ADHD and 









14. Providers should refer suspected ADHD patients when ________ (select all that 
apply). 
a. Comorbid conditions exist 
b. Provider is uncomfortable making the diagnosis 
c. Patient’s diagnosis is not clear 
d. Request is made by the parents 
e. Patient is under 5 years of age 







15. Patients with ADHD must be evaluated by a psychiatric provider ____________. 
a. At initial diagnosis 
b. At least once per year 
c. With any medication (not including dosage) change 
d. As determined by the primary care provider 
 
16. If a stimulant medication is initiated for ADHD and it does not seem to be helping 
the first action is to ________ 
a. Change to a non-stimulant medication  
b. Change to a different stimulant medication 
c. Increase the dose 
d. Re-evaluate ADHD diagnosis 
 
17. If a patient has symptoms of ADHD but does not meet diagnostic criteria the next 
step is to___________. 
a. Educated the parents on normal child behaviors 
b. Evaluate for another condition 
c. Refer for further psychological testing 
d. Schedule a follow-up to reassess 
 




19. Once a diagnosis of ADHD is established the patient needs follow up 
appointments at least ________. 
a. Every 3 months 




20. Which of these medications is recommended if pharmacotherapy is needed in a 5 
year old patient with ADHD? 
a. Guanfacine  




Thank you for your time and participation in this research. 
 
 
